Hemophilia & Bleeding Disorder Treatment
Hemophilia & Bleeding Disorder Treatment provides specialized evaluation and ongoing care for people with hemophilia A, hemophilia B, von Willebrand disease, and other bleeding disorders. These conditions can cause prolonged or unexpected bleeding and require accurate diagnosis, individualized treatment, and regular monitoring.
Comprehensive Diagnosis and Treatment
Treatment begins with a detailed clinical assessment and appropriate blood and coagulation tests to identify the underlying bleeding disorder and determine its severity. Care may include clotting factor replacement therapy, prophylaxis to reduce bleeding episodes, and other hemostatic treatments selected according to the patient’s condition. Modern hemophilia care also considers inhibitors, treatment response, lifestyle, and individual preferences.
Personalized Care for Hemophilia
For patients with hemophilia A or B, the treatment plan may involve standard or extended half-life factor products. Selected patients with hemophilia A may also be considered for non-factor therapies such as emicizumab for regular prophylaxis. Treatment choices should be made with a qualified hematologist based on diagnosis, bleeding pattern, treatment history, and clinical needs.
Managing Bleeding and Long-Term Health
Prompt treatment of significant bleeding is important, particularly when bleeding affects the brain, joints, muscles, abdomen, or other critical areas. Ongoing care can include monitoring for inhibitors, assessment of joint and musculoskeletal health, genetic counseling where appropriate, and guidance for surgery or invasive procedures.